Synsam AB (SYNSAM) - Net Assets

Latest as of March 2026: Skr2.61 Billion SEK ≈ $280.45 Million USD

Based on the latest financial reports, Synsam AB (SYNSAM) has net assets worth Skr2.61 Billion SEK (≈ $280.45 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr8.44 Billion ≈ $908.06 Million USD) and total liabilities (Skr5.83 Billion ≈ $627.62 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore SYNSAM total assets for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric Value
Current Net Assets Skr2.61 Billion
% of Total Assets 30.88%
Annual Growth Rate N/A
5-Year Change -1.77%
10-Year Change N/A
Growth Volatility 3.49

Synsam AB - Net Assets Trend (2018–2025)

This chart illustrates how Synsam AB's net assets have evolved over time, based on quarterly financial data. Check Synsam AB tangible book value ratio to evaluate the tangible quality of the company's equity base.

Annual Net Assets for Synsam AB (2018–2025)

The table below shows the annual net assets of Synsam AB from 2018 to 2025. For live valuation and market cap data, see market value of Synsam AB.

Year Net Assets Change
2025-12-31 Skr2.44 Billion
≈ $262.04 Million
-4.70%
2024-12-31 Skr2.56 Billion
≈ $274.96 Million
+1.55%
2023-12-31 Skr2.52 Billion
≈ $270.76 Million
-2.63%
2022-12-31 Skr2.58 Billion
≈ $278.08 Million
+4.24%
2021-12-31 Skr2.48 Billion
≈ $266.78 Million
+257.44%
2020-12-31 Skr-1.57 Billion
≈ $-169.45 Million
-14.78%
2019-12-31 Skr-1.37 Billion
≈ $-147.63 Million
-14.63%
2018-12-31 Skr-1.20 Billion
≈ $-128.78 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Synsam AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 24630000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock Skr1.00 Million 0.04%
Other Comprehensive Income Skr-3.00 Million -0.12%
Other Components Skr4.30 Billion 176.72%
Total Equity Skr2.44 Billion 100.00%

Synsam AB Competitors by Market Cap

The table below lists competitors of Synsam AB ranked by their market capitalization.

Company Market Cap
DLG Exhibitions & Events Corp Ltd
SHG:600826
$863.21 Million
Dharma Satya Nusantara Ptdsn
JK:DSNG
$863.34 Million
Taihan Fiber Optics Co. Ltd
KQ:010170
$863.45 Million
Hiecise Precision Equipment Co Ltd
SHE:300809
$863.71 Million
Prosperity Dielectrics Co Ltd
TWO:6173
$863.00 Million
Metro Investment Development Co Ltd
SHG:600683
$862.86 Million
Creades AB
ST:CRED-A
$862.67 Million
Guangdong LingXiao Pump Industry Co Ltd
SHE:002884
$862.57 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Synsam AB's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 2,555,000,000 to 2,436,000,000, a change of -119,000,000 (-4.7%).
  • Net income of 454,000,000 contributed positively to equity growth.
  • Dividend payments of 260,000,000 reduced retained earnings.
  • Share repurchases of 206,000,000 reduced equity.
  • Other comprehensive income decreased equity by 115,000,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income Skr454.00 Million +18.64%
Dividends Paid Skr260.00 Million -10.67%
Share Repurchases Skr206.00 Million -8.46%
Other Comprehensive Income Skr-115.00 Million -4.72%
Other Changes Skr8.00 Million +0.33%
Total Change Skr- -4.66%

Book Value vs Market Value Analysis

This analysis compares Synsam AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 3.35x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2018-12-31 Skr-7.98 Skr56.50 x
2019-12-31 Skr-9.15 Skr56.50 x
2020-12-31 Skr-10.50 Skr56.50 x
2021-12-31 Skr16.53 Skr56.50 x
2022-12-31 Skr17.25 Skr56.50 x
2023-12-31 Skr16.88 Skr56.50 x
2024-12-31 Skr17.30 Skr56.50 x
2025-12-31 Skr16.87 Skr56.50 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Synsam AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 18.64%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 6.43%
  • • Asset Turnover: 0.89x
  • • Equity Multiplier: 3.26x
  • Recent ROE (18.64%) is above the historical average (7.51%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2018 0.00% -8.78% 0.53x 0.00x Skr-179.93 Million
2019 0.00% -4.71% 0.55x 0.00x Skr-40.82 Million
2020 0.00% -5.06% 0.53x 0.00x Skr-37.74 Million
2021 2.06% 1.08% 0.62x 3.07x Skr-196.90 Million
2022 12.69% 6.13% 0.67x 3.10x Skr69.60 Million
2023 12.36% 5.27% 0.73x 3.19x Skr59.40 Million
2024 14.32% 5.69% 0.78x 3.23x Skr110.50 Million
2025 18.64% 6.43% 0.89x 3.26x Skr210.40 Million

Industry Comparison

This section compares Synsam AB's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $669,507,200
  • Average return on equity (ROE) among peers: -36.79%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Synsam AB (SYNSAM) Skr2.61 Billion 0.00% 2.24x $863.17 Million
ADDvise Group AB A (ADDV-A) $835.00 Million 10.78% 3.13x $4.23 Million
ADDvise Group B (ADDV-B) $4.25 Million -261.01% 29.33x $108.58 Million
AddLife AB (publ) (ALIF-B) $4.29 Billion 16.76% 1.47x $2.08 Billion
Biotage AB (BIOT) $609.50 Million -40.10% 0.36x $1.23 Billion
Bio-Works Technologies AB (BIOWKS) $22.41 Million -55.16% 0.10x $37.35 Million
Bonesupport Holding AB (BONEX) $727.46 Million 18.39% 0.21x $1.62 Billion
Dynavox Group (DYVOX) $139.50 Million 21.36% 7.22x $833.82 Million
iZafe Group AB Series B (IZAFE-B) $5.42 Million -117.33% 0.49x $15.51 Million
Ortivus AB ser. A (ORTI-A) $29.44 Million 31.28% 1.46x $411.54K
Ortivus AB ser. B (ORTI-B) $31.19 Million 7.12% 0.71x $18.57 Million

About Synsam AB

ST:SYNSAM Sweden Medical Instruments & Supplies
Market Cap
$863.17 Million
Skr8.02 Billion SEK
Market Cap Rank
#9443 Global
#150 in Sweden
Share Price
Skr56.50
Change (1 day)
-0.18%
52-Week Range
Skr51.50 - Skr70.00
All Time High
Skr70.00
About

Synsam AB (publ), together with its subsidiaries, operates in the optical retail and eye health sector in the Nordic Region. The company offers lenses, frames, sunglasses, sports spectacles, contact lenses, eye care accessories, and hearing aids. It also provides eye health services, hearing tests, lifestyle subscriptions, contact lens subscriptions, personal style advice services, and eye examin… Read more